Summary of Patient Monitoring on Therapy for Chronic Hepatitis C


 
  Baseline Treatment Weeks Post Treatment
1 2 4 8 12 16 20 24 28 32 36 40 44 48 4 8 12 24 48
Vital Signs/Weight X         X     X     X     X          
EKGa X                                      
Liver Biopsy X                                      
Hematologyb X X X X X X X X X X X X X X X X X X X  
Complete Blood Chemistryc X         X     X     X     X       X  
Abbreviated Blood Chemistryd       X X   X X   X X   X X   X X X   X
Prothrombin Time/INR X               X           X          
Urine Preganancy Testg X X X X X X X X X X X X X X X X X X X  
TSH X               X     X     X       X  
Alpha-feto proteinf X                                      
ANAe, HbsAge, HIVe X                                      
HCV-RNA (qPCR) X               X           X       X X

aFor patients over the age of 55 years and considering treatment with Ribavirin.
bComplete blood count with platelets and differential, reticulocyte count (if on Ribavirin).
cAST, ALT, alkaline phosphatase, total bilirubin, albumin, electrolytes with BUN/creatinine, glucose.
dAST, ALT, alkaline phosphatase, total bilirubin.
eWithin the past year; ANA = antinuclear antibody; HBsAg = hepatitis B surface antigen, HIV = human immunodeficiency virus
fAlpha-fetoprotein to be done in patients with cirrhosis.
gUrine Pregnancy Test to be done at baseline and as indicated unless you are on Ribavirin then follow schedule above.
 
©Copyright 2000   University of Washington. All rights reserved